Intravenous Solutions Market with COVID-19 Impact Analysis, By Type (Total Parenteral Nutrition & Peripheral Parenteral Nutrition), By Nutrients (single-dose amino acid solutions, carbohydrates, parenteral lipid emulsion, vitamins & minerals, and others), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Intravenous Solutions Market size was valued at USD 11,910.11 Million in 2022, expanding at a CAGR of 8.11% from 2023 to 2030.
Intravenous solutions, often known as IV solutions, are sterile fluids that are injected directly into a patient\'s circulation using a needle or catheter. When a patient is unable to take drugs or nutrients orally, these solutions are carefully designed to give hydration, restore critical electrolytes, and deliver medications or nutrients. IV solutions serve an important role in a variety of medical settings, including hospitals, clinics, and emergency care, by assisting in the maintenance of adequate fluid balance, the support of key biological processes, and the effective administration of medicinal chemicals.
Intravenous Solutions Market- Market Dynamics
- Increasing incidence of diseases like neurological conditions, gastrointestinal disorders, and cancer
The significant growth of the Intravenous Solutions market is driven by the rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer. For effective medicine administration and hydration, many conditions frequently demand intravenous therapy. As a result, demand for intravenous solutions has increased, providing a vital lifeline for patients and contributing to market growth as healthcare practitioners constantly rely on these solutions to treat a wide range of medical ailments. According to the World Health Organization, the global cancer incidence (cases per year) was almost 18.1 million in 2018, with a projected increase to 22.0 million by 2034. Additionally, According to WHO, gastrointestinal diseases impact 60 to 70 million individuals in the United States, increasing the demand for parenteral nutritional solutions including glucose, phospholipids, glutamine, and amino acids.
Intravenous Solutions Market- Key Insights
- As per the analysis shared by our research analyst, the global Intravenous Solutions market is estimated to grow annually at a CAGR of around 8.11% over the forecast period (2023-2030)
- The Intravenous Solutions industry is projected to grow at a significant rate due to the increasing incidence of diseases like neurological conditions, gastrointestinal disorders, and cancer
- Based on Type segmentation, total parenteral nutrition segment was predicted to show maximum market share in the year 2022
- Based on nutrient segmentation, single-dose amino acid was the leading segment in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Intravenous Solutions Market- Segmentation Analysis:
The Global Intravenous Solutions Market is segmented on the basis of Type, Nutrient, and Region.
The market is divided into categories based on Type: Total Parenteral Nutrition and Peripheral Parenteral Nutrition. Total parenteral nutrition is a way of delivering nutritious fluids straight into the vein from the digestive system. These are mostly determined by weight, age, height, and illness. These are typically utilized for gastrointestinal abnormalities, burns or injuries, bowel syndrome, chemotherapy, or other surgical procedures.
The market is divided into categories based on Nutrients: single-dose amino acid solutions, carbohydrates, parenteral lipid emulsion, vitamins & minerals, and others. The market was dominated by single-dose amino acid solutions. According to many studies, single-dose amino acids offer a complete protein supply, may be customized with other parenteral formulations, and are conveniently delivered.
Intravenous Solutions Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North American growth may be ascribed to the existence of important market participants, advantageous laws and regulations, and a solid reimbursement structure in nations such as the United States. For example, Assure Infusions, Inc. announced a USD 20 million investment in 2022 to build an advanced manufacturing plant in Bartow, Florida, to develop IV solutions. The company\'s goal is to close the demand-supply gap for IV solutions in the United States.
Intravenous Solutions Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, In February 2022, B. Braun Medical gained clearance from the US Food and Drug Administration to commence operations at its recently opened IV saline solution manufacturing plant in Daytona Beach, Florida.
Recent Developments:
- In September 2021, CARESAFE IV Administration Sets with an Optional AirStop component were introduced by B. Braun Medical Inc.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INTRAVENOUS SOLUTIONS MARKET KEY PLAYERS
- Vifor Pharma Group
- Vetter Pharma-Fertigung GmbH & Co. KG
- Terumo Corporation
- Smiths Medical (a division of Smiths Group plc)
- Sippex Pharmaceuticals Pvt. Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- JW Pharmaceutical Corporation
- ICU Medical, Inc.
- Hospira (now part of Pfizer Inc.)
- Grifols S.A.
- Fresenius SE & Co. KGaA
- Baxter International Inc.
- Braun Melsungen AG
- Amanta Healthcare Ltd.
GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE
- Total Parenteral Nutrition
- Peripheral Parenteral Nutrition
GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY NUTRIENT
- Single-Dose Amino Acid Solutions
- Carbohydrates
- Parenteral Lipid Emulsion
- Vitamins & Minerals
- Others
GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Intravenous Solutions Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Intravenous Solutions Market Snippet by Type
2.1.2. Intravenous Solutions Market Snippet by Nutrient
2.1.3. Intravenous Solutions Market Snippet by Country
2.1.4. Intravenous Solutions Market Snippet by Region
2.2. Competitive Insights
3. Intravenous Solutions Key Market Trends
3.1. Intravenous Solutions Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Intravenous Solutions Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Intravenous Solutions Market Opportunities
3.4. Intravenous Solutions Market Future Trends
4. Intravenous Solutions Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Intravenous Solutions Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Intravenous Solutions Market Landscape
6.1. Intravenous Solutions Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Intravenous Solutions Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. Total Parenteral Nutrition
7.1.3. Peripheral Parenteral Nutrition
8. Intravenous Solutions Market – By Nutrient
8.1. Overview
8.1.1. Segment Share Analysis, By Nutrient, 2022 & 2030 (%)
8.1.2. Single-Dose Amino Acid Solutions
8.1.3. Carbohydrates
8.1.4. Parenteral Lipid Emulsion
8.1.5. Vitamins & Minerals
8.1.6. Others
9. Intravenous Solutions Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Intravenous Solutions Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Intravenous Solutions Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Intravenous Solutions Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Intravenous Solutions Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Intravenous Solutions Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Nutrient, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Intravenous Solutions Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Vifor Pharma Group
10.2.2. Vetter Pharma-Fertigung GmbH & Co. KG
10.2.3. Terumo Corporation
10.2.4. Smiths Medical (a division of Smiths Group plc)
10.2.5. Sippex Pharmaceuticals Pvt. Ltd.
10.2.6. Sichuan Kelun Pharmaceutical Co., Ltd.
10.2.7. Otsuka Pharmaceutical Co., Ltd.
10.2.8. JW Pharmaceutical Corporation
10.2.9. ICU Medical, Inc.
10.2.10. Hospira (now part of Pfizer Inc.)
10.2.11. Grifols S.A.
10.2.12. Fresenius SE & Co. KGaA
10.2.13. Baxter International Inc.
10.2.14. B. Braun Melsungen AG
10.2.15. Amanta Healthcare Ltd.
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
